FastMoss Achieved #1 on Product Hunt, Reinforcing Its Leadership in TikTok Shop Data Analytics
FastMoss, the world's leading TikTok Shop data analytics platform, proudly announced that it has been named #1 Product of the Day on Product Hunt on July 5, 2025, earning 430 upvotes from the global tech and entrepreneurial community.
With a rapidly growing user base of over 2 million brands, creators, and agencies across 14+ countries, FastMoss is redefining the future of TikTok commerce through cutting-edge, data-driven insights that help businesses stay ahead of market trends, outperform competitors, and achieve sustainable sales growth.
Product Hunt Milestone: A Validation of Market Demand and Innovation
Securing the #1 position on Product Hunt is more than just a symbolic victory—it represents a powerful market validation of FastMoss's unique value proposition and technological innovation.
The recognition underscores the growing demand for intelligent AI solutions that translate data into actionable results—helping brands capitalize on emerging trends, refine influencer strategies, and boost product sales on one of the fastest-growing e-commerce ecosystems in the world.
'Our mission is to build a powerful tool that enables every brand on TikTok Shop to seize the new wave of e-commerce opportunities,' said Eric, CEO of FastMoss. 'We are thrilled by the response from the Product Hunt community and energized by the opportunity to help more businesses thrive in this new digital economy.'
About FastMoss
FastMoss is designed to empower users at every stage of their TikTok Shop journey. Key features include:
Real-Time TikTok Shop Trend Monitoring: Instantly identify product trends and viral content patterns.
Competitor Benchmarking and Analysis: Track and analyze competitor performance for strategic decision-making.
Top Creator Rankings and Influencer Insights: Discover top-performing creators and optimize influencer collaborations.
Sales Acceleration for TikTok Shop: Deliver actionable recommendations to drive product sales and build best-sellers.
FastMoss combines powerful data processing with intuitive design, making it the go-to platform for brands seeking an edge in the rapidly evolving TikTok commerce landscape.
The momentum from Product Hunt reflects FastMoss's accelerating global adoption and the increasing relevance of TikTok Shop as a frontier for online retail. As social commerce continues to reshape consumer behavior, FastMoss is committed to continuous innovation, expanding its feature set, and supporting the success of brands and creators worldwide.
Media Contact
Company Name: FastMoss Inc.
Contact Person: Jody
Email: Send Email
City: Los Angeles
State: California
Country: United States
Website: www.fastmoss.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
DELL's Margins Under Pressure: Will ISG Strength Drive a Rebound Ahead?
Dell Technologies DELL is suffering from a decline in gross margin, which contracted 80 basis points (bps) year over year to 21.6% in the first quarter of fiscal 2026. The dip was primarily driven by a more competitive pricing environment, particularly in the Client Solutions Group segment, and an unfavorable geographical mix within traditional servers. However, Dell's ISG (Infrastructure Solutions Group) segment played a key role in supporting overall gross margin performance. In the first quarter of fiscal 2026, ISG revenues grew 12% year over year to $10.3 billion, with servers and networking revenue reaching a record $6.3 billion, up 16% year over year. The company also saw robust demand for AI servers, which drove higher revenues and gross margin dollars. In the fiscal first quarter of 2026, Dell's AI-optimized server momentum saw an increase of $12.1 billion in orders. The flagship PowerEdge XE9680 experienced strong demand, contributing to the momentum in the AI space. The company shipped $1.8 billion worth of AI servers in the fiscal first quarter, and the AI server backlog remained healthy at $14.4 billion. Building on this momentum, Dell expects gross margin dollars to increase 10% quarter over quarter in the second quarter of fiscal 2026, driven by strong performance in ISG, particularly AI servers, and continued improvement in storage profitability. The company also expects to ship $7 billion worth of AI servers in the second quarter of fiscal 2026, which is expected to contribute significantly to gross margin growth. DELL Faces Stiff Competition From HPE and SMCI DELL is facing stiff competition in the server space against the likes of Hewlett Packard HPE and Super Micro Computers SMCI. Hewlett Packard is benefiting from robust demand for its AI-optimized servers, leading to significant revenue growth in its server segment. The company's multi-billion-dollar investment plan across expanding networking capabilities will diversify the business beyond the server and hardware storage markets, ultimately boosting margins in the long run. Super Micro Computer is evolving from just a server and hardware vendor into a full IT solutions provider. Products like DCBBS (Data Center Building Block Solutions) bundle hardware, software, cooling, networking and support into complete systems. This strategy increases revenue per deal and improves margins. It also makes customers more likely to stay with Super Micro Computer for future upgrades. DELL's Share Price Performance, Valuation and Estimates DELL's shares have gained 7.3% year to date, underperforming the broader Zacks Computer & Technology sector's return of 8.4%. DELL Stock Performance Image Source: Zacks Investment Research DELL stock is trading at a significant discount, with a forward 12-month Price/Sales of 12.36X compared with the Computer & Technology sector's 27.64X. DELL has a Value Score of B. Price/Sales (F12M) The Zacks Consensus Estimate for second-quarter fiscal 2026 earnings is pegged at $2.28 per share, which has increased by a couple of pennies in the past 30 days. This indicates a year-over-year increase of 20.63%. The consensus mark for 2025 earnings is pegged at $9.44 per share, which increased by a penny in the past 30 days. This suggests 15.97% year-over-year growth. DELL currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dell Technologies Inc. (DELL): Free Stock Analysis Report Super Micro Computer, Inc. (SMCI): Free Stock Analysis Report Hewlett Packard Enterprise Company (HPE): Free Stock Analysis Report
Globe and Mail
an hour ago
- Globe and Mail
Abbott Reports 10.5% EPS Growth for Fiscal Q2
Key Points Q2 revenue beat expectations at $11.14 billion, up 7.4% year over year. Adjusted EPS exceeded estimates, reaching $1.26 for Q2 2025, representing 10.5% growth year over year. Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories (NYSE:ABT), a global healthcare company known for its medical devices, diagnostics, nutrition, and pharmaceuticals, reported fiscal 2025 earnings on Thursday, July 17, that narrowly topped analysts' consensus estimates. Q2 revenue climbed to $11.14 billion, surpassing the analyst estimate of $11.06 billion, and adjusted earnings per share came in at $1.26, beating the consensus by $0.01. These results reflect robust year-over-year growth, especially in the company's Medical Devices segment, which reported year-over-year sales growth of 13.4%, but also highlight continued headwinds in its Diagnostics business, mainly in China. Overall, the company achieved margin expansion and affirmed management's full-year outlook despite tariff pressures and competitive and regulatory challenges overseas. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Change (YOY) Adjusted EPS $1.26 $1.25 $1.14 10.5% Revenue $11.14 billion $11.06 billion $10.38 billion 7.4% Adj. operating margin 22.9% 21.9% 100 bps Net earnings $2.21 billion $2.00 billion 10.5% Source: Abbott Laboratories. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. bps = basis points. Understanding Abbott Laboratories' Business Abbott Labs operates across four main segments: medical devices, diagnostics, nutrition, and pharmaceuticals. Its product range includes continuous glucose monitors for diabetes care, implantable heart devices, laboratory diagnostic analyzers, and nutritional products such as Ensure and Glucerna. The company serves customers in over 160 countries, generating a significant portion of sales internationally. The company's ongoing strategy centers on technological innovation, shown in products like its FreeStyle Libre system for continuous glucose monitoring, and compliance with evolving global health regulations. Its global footprint supports market access and supply chain resilience. Success depends on delivering new technology, defending market share, and adapting to changing healthcare policies and competitive pressures. Second-Quarter Highlights The Medical Devices segment was the standout performer. Sales for the segment reached $5.37 billion, up 13.4%, with especially strong contributions from Diabetes Care, Heart Failure, Structural Heart, and Electrophysiology subsegments. Continuous glucose monitoring systems, like the FreeStyle Libre, generated $1.9 billion in revenue -- up 21.4% on a reported basis -- helped by robust adoption in both the U.S. and international markets. New launches, such as Navitor for heart valves and AVEIR leadless pacemakers, also fueled growth. Diagnostics segment sales came in at $2.17 billion, declining 1% from last year. The primary factor was a sharp drop in COVID-19 testing sales, now down to $55 million from $102 million a year earlier. Core Laboratory Diagnostics grew slightly, but ongoing price cuts from China's volume-based procurement program pressured overall segment results. While diagnostics achieved roughly 7% growth outside China in Q1 2025, this did not fully make up for the shortfall in that market. CEO Robert Ford noted the challenge, highlighting that recent changes in Chinese procurement have led to lower prices without offsetting volume gains -- a departure from past patterns. Nutrition revenue was $2.21 billion, up 2.9% on a reported basis. Adult Nutrition -- driven by Ensure and Glucerna brands -- grew 6.1% on a reported basis, while Pediatric Nutrition organic sales remained nearly flat, reflecting a continuing squeeze in international pediatric sales, which fell 5.7%. The adult product growth offset ongoing softness in pediatric lines. Pharmaceutical sales, mostly in established branded generics outside the United States, rose 6.9% on a reported basis, with double-digit gains in emerging markets across Asia, Latin America, and the Middle East. Adjusted operating margin rose to 22.9%, a 100 basis point increase from the prior year. Management cautioned that tariffs introduced in 2025 posed a 'few hundred million dollar' headwind for the second half of the year, but indicated that mitigation strategies -- such as adjusting manufacturing footprints and leveraging foreign exchange rates -- remain in progress. Net earnings reached $2.21 billion. Abbott Laboratories also maintained a quarterly dividend of $0.59 per share, extending its streak of increases to 53 consecutive years. Future Outlook and What to Watch Looking ahead, management reaffirmed its full-year guidance despite new tariff costs. For fiscal 2025, it projects organic sales growth (excluding COVID-19 testing-related sales) of 7.5% to 8.0%, and full-year adjusted EPS in the $5.10–$5.20 range. Third-quarter 2025 adjusted EPS is expected to be between $1.28 and $1.32. Abbott also guided to an adjusted operating margin of 23.5%, implying further focus on efficiency and cost controls. Management sees new product launches and recovery in underperforming segments as growth drivers for the back half of 2025. Investors should closely monitor the ongoing impact of global tariffs, continued performance in the Diagnostics segment -- especially in China -- and the pace at which the company launches new products in its medical devices pipeline. International pediatric nutrition trends also bear watching, given ongoing weakness. Planned mitigation efforts around tariffs and supply chain reshuffling, along with the evolving clinical and regulatory landscape, are likely to influence the company's performance as 2025 progresses. Note: Revenue and net income are presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,059%* — a market-crushing outperformance compared to 180% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of July 14, 2025
Globe and Mail
an hour ago
- Globe and Mail
5 Top-Ranked Gold Mining Stocks Amid Strong Central Bank Purchases
Gold prices are witnessing a northward journey this year, benefiting the stocks associated with yellow metal mining. The momentum of yellow metal is likely to continue as the World Gold Council has stated that the gold mining industry is facing a scarcity of deposits. On the demand side, several central banks of emerging economies are continuously buying the yellow metal. At this stage, it will be fruitful to buy gold mining stocks with a favorable Zacks Rank. Five such stocks are: Franco-Nevada Corp. FNV, Royal Gold Inc. RGLD, Kinross Gold Corp. KGC, AngloGold Ashanti plc AU and Agnico Eagle Mines Ltd. AEM. Each of our picks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. Solid Gold Demand by Central Banks Central Banks are bolstering their gold reserves following rising global debt levels, trade and tariff-related uncertainties and lingering geopolitical risks, especially in the Middle East. Central bankers are purchasing more gold from local miners without weighing on foreign exchange reserves, especially the U.S. dollar. Spot gold price is currently around $3,342/oz, up 37% year to date. Moreover, central banks across the world are in the process of cutting interest rates in order to spur economic growth. A low market interest rate is beneficial for non-income-bearing bullions like gold. Additionally, the use of gold in energy, healthcare and technology is rising. Therefore, an eventual demand-supply imbalance is likely to drive gold prices. Market participants are optimistic about the gold mining industry's prospects. Giant investment bankers like Goldman Sachs and JP Morgan have forecasted that gold prices could climb to $4,000/ounce by 2026, suggesting continued bullish momentum. The chart below shows the price performance of our five picks year to date. Franco-Nevada Corp. Franco-Nevada is well-poised to deliver strong earnings growth aided by increased contributions from its streaming agreements. Contribution from buyouts and a healthy portfolio of royalty and streaming agreements will aid the growth of FNV. Even though the company has been facing lower output due to the production halt in Cobre Panama, it is likely to be offset by FNV's continued focus on cost management. FNV has a debt-free balance sheet and uses its free cash flow to expand portfolio and pay out dividends. Gold prices have been on an uptrend in 2025, aided by geopolitical reasons, and the potential for monetary policy easing. This rise in gold price will also boost the results of FNV in the coming quarters. Franco-Nevada has an expected revenue and earnings growth rate of 34.6% and 43.9%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.2% over the last seven days. Royal Gold Inc. Royal Gold has been benefiting from its solid streaming agreements. RGLD has been benefiting from its acquisitions and strong business model. Despite persistent inflationary pressures in the broader economy, the company has been maintaining high margins. RGLD maintains a strong balance sheet, which is likely to drive growth in the upcoming quarters. This rise in metal prices, like gold and silver, will boost RGLD's results in the coming quarters. RGLD is focused on allocating its strong cash flow to dividends, debt reduction and new businesses. Royal Gold has an expected revenue and earnings growth rate of 28.8% and 42%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 4.5% over the last 30 days. Kinross Gold Corp. Kinross Gold has a strong production profile and boasts a promising pipeline of exploration and development projects. These projects are expected to boost production and cash flow and deliver significant value. KGC is focusing on organic growth through its Tasiast mine, where the Phase One expansion boosted production capacity, and the Tasiast 24K expansion further increased throughput and production. KGC's Manh Choh project at Fort Knox is expected to extend operations and benefit from higher gold prices. The Great Bear project in Ontario also offers a promising long-term opportunity with substantial gold resources. Higher gold prices should also boost KGC's profitability and drive cash flow generation. Kinross Gold has an expected revenue and earnings growth rate of 17.9% and 72.1%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.4% over the last 30 days. AngloGold Ashanti plc AngloGold Ashanti operates as a gold mining company in Africa, Australia, and the Americas. AU primarily explores for gold, as well as produces silver and sulphuric acid as by-products. AU's flagship property is a fully owned Geita mine located in the Lake Victoria goldfields of the Mwanza region in north-western Tanzania. AngloGold Ashanti has an expected revenue and earnings growth rate of 52.8% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.6% over the last 30 days. Agnico Eagle Mines Ltd. Agnico Eagle Mines is focused on executing projects that are expected to provide additional growth in production and cash flows. AEM is advancing its key value drivers and pipeline projects. The Kittila expansion promises cost savings, while acquisitions like Hope Bay and the merger with Kirkland Lake Gold strengthen AEM's market position. The merger with Kirkland Lake Gold established the new Agnico Eagle as the industry's highest-quality senior gold producer. Higher gold prices are also expected to drive AEM's margins. Strategic diversification mitigates risks, supported by prudent debt management and maintaining financial flexibility. Agnico Eagle Mines has an expected revenue and earnings growth rate of 26.6% and 52.5%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 7% over the last 30 days. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kinross Gold Corporation (KGC): Free Stock Analysis Report AngloGold Ashanti PLC (AU): Free Stock Analysis Report Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report Franco-Nevada Corporation (FNV): Free Stock Analysis Report Royal Gold, Inc. (RGLD): Free Stock Analysis Report
